glp 1 agonists vs sglt2 inhibitors or GLP-1 receptor as second-line therapy in | VHRM Effect of combination treatment with

doi: 10.1002/jcsm.13677 43 BianXWangQWangYLouS

When combined with the exclusion of patients with either acute or chronic pancreatitis from prior clinical trials, this observation aligns with the caution raised by the American Diabetes Association to avoid use of GLP-1RAs for patients with any history of acute or chronic pancreatitis 27

Ann Intern Med

Role of insulin receptor substance-1 modulating PI3K/Akt insulin signaling pathway in alzheimers disease

"As clinicians, recognizing that people can get double benefits from something is always helpful and as more obesity medications enter the market, this can help personalize treatments," she said

The intervention protocols differed by study design